_1777352142843_145525226.png&w=64&q=75){kind=small}
Genvax Egypt signs new tech transfer deal
An agreement has been signed between GenVax Egypt and China's Minhai company to transfer the technology for manufacturing the 20-valent pneumococcal vaccine (PCV-20) to Egypt. The goal is to expand collaboration in vaccine manufacturing and localize the production technology. This initiative comes as part of efforts to support the development of national capabilities and strengthen Egypt’s vaccine industry. The Head of the Drug Authority visited the PCM-13 vaccine production line and discussed areas of cooperation that contribute to improving pharmaceutical security and increasing industrial capacity. The partnership aims to transfer technology, develop technical skills, expand the local and regional markets, and achieve greater sustainability and competitiveness for Egypt’s pharmaceutical industry.
Notice: This Is an AI-Generated Summary
Comments (0)